ATLASPassage Bio (PASG) earnings date: Nov 9, 2026
Passage Bio (PASG) reports earnings for the quarter ended Sep 30, 2026 on Mon, Nov 9, 2026. Analysts expect EPS of -$2.43.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on PASG
| Last price | $3.45 (-2.0%) |
|---|---|
| Normal 1-day range (±1σ) | ±5.2% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Passage Bio stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Passage Bio reports on Nov 9, 2026. One email the day before, with ATLAS’s read on Passage Bio. You can switch it off at any time.
Alert me before PASG reportsFree to start. Creating an account takes under a minute.
PASG earnings at a glance
| Next report (confirmed) | Mon, Nov 9, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$2.43 |
| Last report | Aug 10, 2026 · Beat |
| Beat rate (last 4 reports) | 3 of 4 (75%) |
| Average EPS surprise | +15.1% |
| Average move around a report | ±6.1% (last 4) |
| Sector | Healthcare · Biotechnology |
Passage Bio earnings history: last 4 reports
Passage Bio last reported on Aug 10, 2026: EPS of -$2.44 against an estimate of -$2.83 (+13.8% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 10, 2026 | -$2.83 | -$2.44 | +13.8% | Beat | +2.3% |
| May 8, 2026 | $0.11 | $0.13 | +18.2% | Beat | +7.8% |
| Mar 27, 2026 | -$3.78 | -$0.97 | +74.3% | Beat | -10.3% |
| Mar 3, 2026 | -$2.80 | -$4.09 | -46.1% | Miss | -3.9% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for PASG
See the fair value, the probability range and the earnings history of Passage Bio on its ATLAS page.
Passage Bio (PASG) stock analysisPlans from €3.99 a month.
Passage Bio earnings: frequently asked questions
When does Passage Bio (PASG) report earnings?
Passage Bio is scheduled to report on Monday, November 9, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for PASG?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$2.43 per share (USD). Estimates can change before the report.
How often does PASG beat earnings estimates?
Of its last 4 reports with a recorded result, Passage Bio beat the EPS estimate 3 times; the average surprise was +15.1%. Past results do not predict the next one.
How much does PASG move around earnings?
Over its last 4 reports the stock moved an average of 6.1% (absolute, from the close before the report day to the close after it), and finished higher 2 of 4 times.
Did Passage Bio beat earnings estimates last quarter?
Passage Bio last reported on Aug 10, 2026: EPS of -$2.44 against an estimate of -$2.83 (+13.8% surprise), a beat.
How much does PASG usually move in a day?
On a normal trading day the ATLAS model puts PASG’s one-day range at about ±5.2%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Mon, Nov 9, 2026
Educational information, not investment advice. Disclaimer